These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16174409)

  • 21. Levels and interactions of plasma xanthine oxidase, catalase and liver function parameters in Nigerian children with Plasmodium falciparum infection.
    Iwalokun BA; Bamiro SB; Ogunledun A
    APMIS; 2006 Dec; 114(12):842-50. PubMed ID: 17207084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study.
    Bruneel F; Tubach F; Mira JP; Houze S; Gibot S; Huisse MG; Megarbane B; Choquet C; Corne P; Peytel E; Villers D; Camus C; Bouchaud O; Caumes E; Girard PM; Simon F; Kalloumeh A; Roy C; Durand R; Le Bras J; Matheron S; Wolff M;
    Intensive Care Med; 2016 Oct; 42(10):1588-1596. PubMed ID: 27169586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ibuprofen does not affect levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptor types I and II in Gabonese children with uncomplicated Plasmodium falciparum malaria.
    Matsiegui PB; Missinou MA; Issifou S; Necek M; Mavoungou E
    Eur Cytokine Netw; 2007 Dec; 18(4):201-5. PubMed ID: 17964975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating sequestered parasite population dynamics in cerebral malaria.
    Gravenor MB; van Hensbroek MB; Kwiatkowski D
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7620-4. PubMed ID: 9636199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Schistosomiasis co-infection in humans influences inflammatory markers in uncomplicated Plasmodium falciparum malaria.
    Diallo TO; Remoue F; Schacht AM; Charrier N; Dompnier JP; Pillet S; Garraud O; N'diaye AA; Capron A; Capron M; Riveau G
    Parasite Immunol; 2004; 26(8-9):365-9. PubMed ID: 15679634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-treatment with chloroquine and parasite chloroquine resistance in Ghanaian children with severe malaria.
    Evans JA; May J; Tominski D; Eggelte T; Marks F; Abruquah HH; Meyer CG; Timmann C; Agbenyega T; Horstmann RD
    QJM; 2005 Nov; 98(11):789-96. PubMed ID: 16186171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2.
    Dondorp AM; Desakorn V; Pongtavornpinyo W; Sahassananda D; Silamut K; Chotivanich K; Newton PN; Pitisuttithum P; Smithyman AM; White NJ; Day NP
    PLoS Med; 2005 Aug; 2(8):e204. PubMed ID: 16104831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyper parasitaemia due to plasmodium falciparum malaria.
    Mehta SR
    J Assoc Physicians India; 1994 Jun; 42(6):510. PubMed ID: 7852251
    [No Abstract]   [Full Text] [Related]  

  • 29. Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria.
    Happi CT; Gbotosho GO; Folarin OA; Bolaji OM; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
    Am J Trop Med Hyg; 2006 Jul; 75(1):155-61. PubMed ID: 16837724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed parasite elimination in human infections treated with clindamycin parallels 'delayed death' of Plasmodium falciparum in vitro.
    Burkhardt D; Wiesner J; Stoesser N; Ramharter M; Uhlemann AC; Issifou S; Jomaa H; Krishna S; Kremsner PG; Borrmann S
    Int J Parasitol; 2007 Jun; 37(7):777-85. PubMed ID: 17280676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic efficacy and effects of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum malaria in southwestern Nigeria.
    Sowunmi A; Gbotosho GO; Happi CT; Adedeji AA; Fehintola FA; Folarin OA; Tambo E; Fateye BA
    Am J Trop Med Hyg; 2007 Aug; 77(2):235-41. PubMed ID: 17690392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.
    Boggild AK; Krudsood S; Patel SN; Serghides L; Tangpukdee N; Katz K; Wilairatana P; Liles WC; Looareesuwan S; Kain KC
    Clin Infect Dis; 2009 Sep; 49(6):841-9. PubMed ID: 19673614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria.
    Hemmer CJ; Holst FG; Kern P; Chiwakata CB; Dietrich M; Reisinger EC
    Trop Med Int Health; 2006 Jun; 11(6):817-23. PubMed ID: 16772003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of quinine monotherapy for the treatment of Plasmodium falciparum infection in pregnant women in Lambaréné, Gabon.
    Adegnika AA; Breitling LP; Agnandji ST; Chai SK; Schütte D; Oyakhirome S; Schwarz NG; Grobusch MP; Missinou MA; Ramharter M; Issifou S; Kremsner PG
    Am J Trop Med Hyg; 2005 Aug; 73(2):263-6. PubMed ID: 16103585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of intraleukocytic Plasmodium falciparum malaria pigment with disease severity, clinical manifestations, and prognosis in severe malaria.
    Lyke KE; Diallo DA; Dicko A; Kone A; Coulibaly D; Guindo A; Cissoko Y; Sangare L; Coulibaly S; Dakouo B; Taylor TE; Doumbo OK; Plowe CV
    Am J Trop Med Hyg; 2003 Sep; 69(3):253-9. PubMed ID: 14628940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parasite multiplication potential and the severity of Falciparum malaria.
    Chotivanich K; Udomsangpetch R; Simpson JA; Newton P; Pukrittayakamee S; Looareesuwan S; White NJ
    J Infect Dis; 2000 Mar; 181(3):1206-9. PubMed ID: 10720557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptosis: a potential triggering mechanism of neurological manifestation in Plasmodium falciparum malaria.
    Touré FS; Ouwe-Missi-Oukem-Boyer O; Bisvigou U; Moussa O; Rogier C; Pino P; Mazier D; Bisser S
    Parasite Immunol; 2008 Jan; 30(1):47-51. PubMed ID: 18086016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlations between treatment outcome and both anti-MSP119 antibody response and erythrocyte-related genetic factors in Plasmodium falciparum malaria.
    Aubouy A; Migot-Nabias F; Deloron P
    Infect Genet Evol; 2007 Mar; 7(2):147-54. PubMed ID: 16890498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of PCR-RFLP and Genescan-based genotyping for analyzing infection dynamics of Plasmodium falciparum.
    Falk N; Maire N; Sama W; Owusu-Agyei S; Smith T; Beck HP; Felger I
    Am J Trop Med Hyg; 2006 Jun; 74(6):944-50. PubMed ID: 16760501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
    Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
    P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.